Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kcentra vs Plasma for Rapid Reversal of VKA-induced Coagulopathy in Urgent Surgery
NCT00803101Phase 3Completed
- Sponsor
- CSL Limited
- Start
- Feb 2009
- Primary completion
- Nov 2012
- Countries
- 6
01
Overview
A Phase 3 trial of coagulation factor ix in coagulopathy, sponsored by CSL Limited. Started Feb 2009; status: completed.
02
Drugs
coagulation factor ix
03
Conditions
coagulopathy
Beyond the preview
Go deeper on NCT00803101.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00803101.